Diabetes Insipidus Flashcards

1
Q

The posterior pituitary is derived from the ______brain during development and is composed predominantly of _____________.
 It lies below the ____________, with which it forms a structural and functional unit→ the _______________.

A

forebrain ; neural tissue.

hypothalamus

neurohypophysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The neurohypophysis consists of
three parts:
 the __________ and _____________ nuclei of the hypothalamus
 the ________________ tract
 the _____________ pituitary

A

supraoptic

paraventricular

supraoptico-hypophyseal

posterior pituitary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

the supraoptic and
paraventricular nuclei of the
hypothalamus contains the cell bodies of the magnocellular,neurosecretory neurons that synthesize and secrete ____________ (also called _________) and __________)

A

antidiuretic hormone[ADH]

vasopressin; Oxytocin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The principle physiological effect of ADH is in the regulation of ____________ in the (proximal or distal?) nephron.

A

water resorption

Distal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ADH stimulates the expression of a specific water channel protein (__________) on the __________ surface of the interstitial cells lining the collecting duct.

The presence of this in the wall of the distal nephron allows ______________________ from the duct lumen along an osmotic gradient, and excretion of concentrated
urine.

A

aquaporin

luminal

resorption of water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diabetes insipidus (DI) is characterized by:
 production of ________________ urine in excess of _____litres/24 hours
 (>40 ml/kg/24 hours in adults,
 >____ ml/kg/24 hours in infants
 or >4ml/kg/hour)
 excessive ______

A

severely dilute

3litres

100 ; thirst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

DI arises through one of three mechanisms :

 ____________ of _______: ________ (Central) DI (HDI)
 ___________ to the ________________ : __________ DI (NDI)
 Inappropriate, ____________________: ___________ DI (DDI).

A

Deficiency of ADH

Hypothalamic

Renal resistance to the antidiuretic action of ADH

Nephrogenic DI (NDI)

excessive water drinking

Dipsogenic DI (DDI).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Central DI

Primary Causes:
Genetic
 DIDMOAD (________) syndrome
•Autosomal dominant
•Autosomal recessive
 Developmental syndromes : _________ dysplasia
 Idiopathic

A

Wolfram

Septo-optic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Central DI

Secondary/Acquired causes:
 Trauma- Head injury
- Post surgery (transcranial,
transphenoidal)
 Tumour:
 Craniopharyngioma
 Germ cell tumours
 Metastases
 Pituitary macroadenoma

A

Secondary/Acquired causes:
 Trauma- Head injury
- Post surgery (transcranial,
transphenoidal)
 Tumour:
 Craniopharyngioma
 Germ cell tumours
 Metastases
 Pituitary macroadenoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Central DI

Secondary/Acquired causes:
 Vascular
 Aneurysm
 Infarction
 Sheehan’s syndrome
 Sickle cell disease
 Drugs-
 Meperidine, MgSO4, phenytoin, barbiturates,
glucocorticoids

A

Secondary/Acquired causes:
 Vascular
 Aneurysm
 Infarction
 Sheehan’s syndrome
 Sickle cell disease
 Drugs-
 Meperidine, MgSO4, phenytoin, barbiturates,
glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nephrogenic DI

Genetic
 ______________ (V2-R defect)
 ______________ (AQP2 defect)
 ______________(AQP2 defect)

Idiopathic

A

Genetic
 X-linked recessive (V2-R defect)
 Autosomal recessive (AQP2 defect)
 Autosomal dominant (AQP2 defect)
Idiopathic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nephrogenic DI

Secondary/Acquired causes:
 Chronic renal disease: Polycystic kidneys, Obstructive uropathy
 Metabolic disease: Hypercalcaemia, Hypokalaemia
 Drug induced : Lithium, Demeclocycline
 Osmotic diuretics : Glucose, Mannitol
 Systemic disorders: Amyloidosis, Myelomatosis
 Pregnancy

A

Secondary/Acquired causes:
 Chronic renal disease: Polycystic kidneys, Obstructive uropathy
 Metabolic disease: Hypercalcaemia, Hypokalaemia
 Drug induced : Lithium, Demeclocycline
 Osmotic diuretics : Glucose, Mannitol
 Systemic disorders: Amyloidosis, Myelomatosis
 Pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dispogenic DI

Compulsive water drinking
 Associated with _________ disorders
 Structural/organic hypothalamic disease:
 ____________
 ________ involving hypothalamus
 Head injury
 ___________ __________

A

affective

Sarcoidosis

Tumours

Tuberculous meningitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DI: signs and symptoms

 _________
 ____________, may not be readily apparent ( b/c of _______-osmolarity, fluid shifts from ______ to __________ and maintains blood pressure, CVP)
 _________ is a better measure of fluid status

A

Polyuria

Dehydration, ; hyper-osmolarity

cells ; intravascular spaces

Weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DI: investigation

 ________ _________
 ______ ____________
 _______ __________
 ________ ________

A

Serum osmolality
 Urine osmolality
 Serum sodium
 Urine sodium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Central DI: Lab values

Hypernatremia, Na >_____-____meq/L
 (low or high?) serum osmolality (normal value is 270mOsm/kg)
 Urine Na < _____ mmol/L
 (low or high ?) urine osmolality (very dilute urine)

A

150-160meq/L
High
20 mmol/L
Low

17
Q

The water deprivation test- assessing the capacity to ____________ during the
osmotic stress of _________________

A

concentrate urine

controlled water deprivation

18
Q

Central DI treatment

•_________ease oral free water consumption, IV can use _____tonic saline
 Volume _____________

Those with significant symptoms require
______________ :
 intranasal spray (5-100 mcg daily);
 parenteral injection (0.1-2.0 mcg daily)
 or oral (100-1000 mcg daily),
in divided doses
 Treat underlying cause

A

Increase

hypotonic

replacement

Desmopressin

19
Q

Nephrogenic DI

•No specific therapy exists.
 High dose _________ (4 mcg im. bd) can produce a response in __________ NDI, especially if the lesion is ____________.
 Reducing GFR and reducing diluting capacity
of the distal nephron by using:
 _____________ : hydrochlorothiazide 25
mg/24 hours.
 ________ : Ibuprofen 200 mg/24 hours.
 __________ diets.

A

Desmopressin ; partial

acquired.

Thiazide ; NSAIDs

Low salt

20
Q

Dispogenic DI

Address the underlying disorder.
 Switching to _________ may reduce polydipsia in those patients with refractory ___________ and a history of _____________ on other dopamine antagonists.
 Reduced fluid intake

A

Clozapine

schizophrenia

hyponatraemia

21
Q

SIADH

Definition: When levels of _______ are
__________________ compared to the
body’s (low or high?) osmolality, and ADH levels are not suppressed by further _______eases in blood
osmolality.

A

ADH

inappropriately elevated

low ; decreases

22
Q

Why we worry about SIADH

The resulting hyponatraemia (a plasma
sodium concentration less than _______ meq/l)
 is a common source of __________ and increased __________ in clinical practice.

A

130

morbidity

mortality

23
Q

SIADH: causes

•Irritation of CNS: _________ , _________,
brain _________, brain _________, hypoxic
insult, trauma, brain abscess, _________ syndrome, hydrocephalus

•Pulmonary disorders: _________ , _________, positive end expiratory pressure ventilation, _________ failure, TB, pneumothorax

A

meningitis, encephalitis,

brain tumors, brain hemorrhage,

Guillain Barre

pneumonia, asthma,

cardiac failure

24
Q

SIADH: causes

Drugs:
__________
____________
 opiates
 carbamazepine
 cyclophosphamide
 NSAIDs
 TCAs
 Haloperidol

A

vincristine

vinblastine

25
SIADH : causes Unregulated tumor production of ADH-like peptides: such as _________ carcinoma, _________ sarcoma
oat cell lung Ewing’s
26
SIADH: signs and symptoms  ______eased urine output  Signs of hyponatremia: __________ , apathy, disorientation, muscle __________, anorexia, agitation  Signs of __________ toxicity: nausea, __________, __________ changes, __________, combativeness  If Na < ______ mEq/L , can develop __________, bulbar palsies, hypothermia, stupor, coma
Decreased lethargy; cramps water ; vomiting personality ; confusion, 110 ; seizures
27
SIADH: lab investigations  Serum Na < 135meq/L  Serum osmolality (low or high?) ,  Urine Na is inappropriately (low or high?) , >20 mmol/L,  Urine osmolality is inappropriately (low or high?)  CVP is high from free water retention  Plasma Renin Activity (PRA)-(low or high?)  Unsuppressed ______________
low high ; high low aldosterone
28
SIADH : treatment Fluid restriction, ____ to ———maintenance  In severe cases with convulsions, confusion or coma, need to replace sodium, using _____________  Diuretics eg __________  Treat underlying disorder
2/3 to 1/2 hypertonic saline Furosemide
29
SIADH: treatment _____________ (blocks ADH receptors in the renal collecting ducts) may be used in younger children to create _____________ allowing more intake for better growth.  In severe cases, hemodialysis may be necessary  Other modalities include  Lithium,  oral Urea &  V2 receptor antagonists.
Demeclocycline nephrogenic DI
30